Exosomica
The goal of biotechnology startup Exosomica, is to develop and commercialise advanced therapies against Parkinson’s disease. Exosomica was founded in 2019 by Dr. Augustas Pivoriūnas, the leading stem cell researcher in Lithuania and the science management, consulting and investment company. Exosomica has received a nearly 1 Mio EUR investment throu EU funds for a research project. During the project, Exosomica aims to develop the technology for the production and therapeutic use of small-scale laboratory exosomes. We believe that our the new technology will help for millions people who are suffering from Parkinson`s decease.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Exosomica
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Exosomica
2 distinct titles indexed · top 2 shown.
- 1chief executive officer
- 1researcher
Sign up to unlock all 2 contacts at Exosomica
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Exosomica
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.